Ghobrial, R. Mark

Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study

Kudo, M., Ren, Z., Guo, Y., Han, G., Lin, H., Zheng, J., Ogasawara, S., Kim, J. H., Zhao, H., Li, C., et al. (2025) · The Lancet

Hepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and Studies

Cited by 342

An imageomics and multi-network based deep learning model for risk assessment of liver transplantation for hepatocellular cancer

He, T., Fong, J. N., Moore, L. W., Ezeana, C. F., Victor, D., Divatia, M., Vasquez, M., Ghobrial, R. M., & Wong, S. T. C. (2021) · Computerized Medical Imaging and Graphics

Radiomics and Machine Learning in Medical ImagingHepatocellular Carcinoma Treatment and Prognosis

Cited by 63

Pericytes, Microvasular Dysfunction, and Chronic Rejection

Kloc, M., Kubiak, J. Z., Li, X. C., & Ghobrial, R. M. (2015) · Transplantation

Barrier Structure and Function StudiesTransplantation: Methods and Outcomes

Cited by 34

Combined liver transplantation and sleeve gastrectomy: report of a brief-interval staged approach

Tariq, N., Saharia, A., Nwokedi, U., Hobeika, M. J., Mobley, C. M., Hsu, D., Potter, L. M., Moore, L. W., Elaileh, A., Sherman, V., et al. (2023) · Liver Transplantation

Organ Transplantation Techniques and OutcomesBariatric Surgery and Outcomes

Cited by 21

Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium

Verna, E. C., Phipps, M. M., Halazun, K. J., Markovic, D., Florman, S. S., Haydel, B. M., Ruiz, R., Klintmalm, G., Lee, D. D., Taner, B., et al. (2023) · Liver Transplantation

Hepatocellular Carcinoma Treatment and PrognosisOrgan Transplantation Techniques and Outcomes

Cited by 16